Skip to content
lifestyle.cosmeticsurgeryinsider.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
DBV Technologies S.A.
Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF
July 6, 2026
DBV Technologies Provides BLA Submission Update for the VIASKIN® Peanut Patch in Children Aged 4 through 7 Years; Working Collaboratively with FDA to Optimize Review Process in Preparation for Filing
June 29, 2026
DBV Technologies Announces Inclusion in the Euronext Tech Leaders Index
June 23, 2026
DBV Technologies Announces the Results of its 2026 Combined General Meeting
June 3, 2026
Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of May 31, 2026
June 3, 2026
DBV Technologies Announces First Participant Screened in THRIVE Phase 2 Study of the VIASKIN® Peanut Patch in Infants ages 6 through 12 Months with Peanut Allergy
June 2, 2026
Combined General Meeting of June 3, 2026
May 13, 2026
DBV Technologies to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at Nasdaq
May 12, 2026
Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of January 31, 2026
February 11, 2026
←
Previous Page
1
2